Terbinafine Hydrochloride
Product Images NDC 68151-1327

5 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 68151-1327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a183255-figure-01 (3a183255 Figure 01)

3a183255-figure-01 (3a183255 Figure 01)
A data table comparing adverse events and discontinuation rates between Lamisil and placebo groups. It lists percentages of subjects experiencing various symptoms such as headache, gastrointestinal, dermatological symptoms, liver enzyme abnormalities, taste disturbance, and visual disturbance, along with sample sizes for each group.*
FDA Label Image

3a183255-figure-02 (3a183255 Figure 02)

3a183255-figure-02 (3a183255 Figure 02)
Chemical structure of Terbinafine Hydrochloride showing the molecular arrangement with a naphthalene group, an amine side chain, and a hydrocarbon tail, including the hydrochloride (HCl) component.*
FDA Label Image

3a183255-figure-03 (3a183255 Figure 03)

3a183255-figure-03 (3a183255 Figure 03)
A text panel listing side effects associated with Terbinafine Hydrochloride, including nausea, stomach (abdominal) pain, rash, headache, vomiting, dizziness, and frequent urination. The formatting is bullet points, arranged in two columns.*
FDA Label Image

3a183255-figure-04 (3a183255 Figure 04)

3a183255-figure-04 (3a183255 Figure 04)
A partial Drug Facts panel listing possible side effects of the medication Terbinafine Hydrochloride. The visible side effects include nausea, poor appetite, tiredness, vomiting, abdominal pain in the upper right stomach, jaundice (yellowing of skin or eyes), dark tea-colored urine, and pale or light colored stools.*
FDA Label Image

Label Image (68151 1327)

Label Image (68151 1327)
Label for Terbinafine 250 mg tablet by InvaGen, showing lot number, expiration date of 09/14, and a barcode. The label also includes the product code PDM: 1327 and indicates the medication is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.